•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Ardagh Metal Packaging: This 8% Yielder Still Looks Great
Ardagh Metal Packaging to participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference
Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward
Ardagh Metal Packaging S.A. Declares Quarterly Dividend
Ardagh Metal Packaging S.A. - First Quarter 2026 Results
Ardagh Metal Packaging: Execution Holds, Tailwinds Build, Valuation Undemanding
Ardagh Metal Packaging S.A. - Fourth Quarter and Full Year 2025 Results
Ardagh Metal Packaging S.A. Declares Quarterly Dividend
Ardagh Metal Packaging: A Shift In Fortunes, But Don't Get Too Excited Now
Aardvark Therapeutics Announces FDA Submission and IRB Approval of Amended Trial Protocol for Lead Candidate ARD-101, Expanding Eligibility in Phase 3 Study of Prader-Willi Syndrome
Ardagh Metal Packaging: A High Yield Built On Cash Flow, Not Accounting Earnings
NYSE to Commence Delisting Proceedings With Respect to Warrants of Ardagh Metal Packaging S.A. (AMBP.WS)
Ardagh Metal Packaging S.A. Release of Supplemental Company Information
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
Ethic Inc. Purchases 12,347 Shares of Ardagh Metal Packaging S.A. $AMBP
Ardagh Metal Packaging S.A. Declares Quarterly Interim Dividend
Ardagh Metal Packaging S.A. - Third Quarter 2025 Results
Ardagh Metal Packaging: Improving Debt And Discount To Peers Could Set Off A Re-Rate
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
Ardagh Group S.A. Announces Comprehensive Recapitalization Transaction